Latest breast and ovarian cancer Stories
AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June
Mutations in the BRCA1 and BRCA2 genes account for nearly 25 percent of hereditary breast cancers and most hereditary ovarian cancers, yet a study by cancer prevention and control researchers at Virginia Commonwealth University Massey Cancer Center suggests an alarmingly small amount of women who qualify for BRCA genetic counseling actually receive the services.
Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers.
FORCE Recognizes Families Affected by Hereditary Breast and Ovarian Cancer with Special Events Throughout the Country (*Previvors are those who carry the gene mutation but have not developed cancer.)
Discovered through a new study, many doctors reported in a questionnaire that they do not appropriately offer breast and ovarian cancer counseling and testing services to their female patients.
CHICAGO, Sept. 14 /PRNewswire/ -- Giuliana Rancic and Lindsay Avner, founder of the national breast and ovarian cancer non-profit Bright Pink, are "feeling themselves up" to fight breast cancer on September 16th.
SALT LAKE CITY, Sept. 14 /PRNewswire-FirstCall/ -- Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio.
NEW YORK (Reuters Health) - A new statement from the US Preventive Services Task Force recommends against routine testing for mutations in the BRCA1 and BRCA2 genes linked to breast and ovarian cancer unless women have a suggestive family history.
- a meat pie that is usually eaten at Christmas in Quebec